K Matoušovic

1.5k total citations
66 papers, 1.2k citations indexed

About

K Matoušovic is a scholar working on Nephrology, Molecular Biology and Epidemiology. According to data from OpenAlex, K Matoušovic has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Nephrology, 13 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in K Matoušovic's work include Renal Diseases and Glomerulopathies (27 papers), Renal function and acid-base balance (10 papers) and Renal Transplantation Outcomes and Treatments (7 papers). K Matoušovic is often cited by papers focused on Renal Diseases and Glomerulopathies (27 papers), Renal function and acid-base balance (10 papers) and Renal Transplantation Outcomes and Treatments (7 papers). K Matoušovic collaborates with scholars based in Czechia, United States and Japan. K Matoušovic's co-authors include Jiří Městecký, Bruce A. Julian, Jan Novák, Milan Tomana, K Konecný, Zina Moldoveanu, Thomas P. Douša, P Roßmann, Lea Novak and Eduardo N. Chini and has published in prestigious journals such as Journal of Clinical Investigation, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

K Matoušovic

63 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Matoušovic Czechia 15 764 329 317 255 214 66 1.2k
Alice C. Allen United Kingdom 19 1.0k 1.3× 401 1.2× 522 1.6× 343 1.3× 259 1.2× 29 1.4k
Huiping Chen China 20 466 0.6× 273 0.8× 153 0.5× 84 0.3× 186 0.9× 56 1.2k
Peter Topham United Kingdom 18 682 0.9× 389 1.2× 415 1.3× 60 0.2× 101 0.5× 29 1.4k
F. W. Ballardie United Kingdom 17 476 0.6× 221 0.7× 153 0.5× 118 0.5× 113 0.5× 37 925
Kazuya Takasawa Japan 15 463 0.6× 197 0.6× 419 1.3× 212 0.8× 76 0.4× 27 1.3k
Morito Endo Japan 20 508 0.7× 252 0.8× 574 1.8× 220 0.9× 48 0.2× 59 1.1k
Sunao Maki Japan 13 456 0.6× 131 0.4× 141 0.4× 114 0.4× 78 0.4× 30 785
Siân Griffin United Kingdom 20 772 1.0× 448 1.4× 181 0.6× 44 0.2× 103 0.5× 48 1.6k
Naofumi Imai Japan 20 526 0.7× 357 1.1× 189 0.6× 126 0.5× 136 0.6× 80 1.3k
Michele Carraro Italy 19 899 1.2× 323 1.0× 125 0.4× 55 0.2× 163 0.8× 60 1.2k

Countries citing papers authored by K Matoušovic

Since Specialization
Citations

This map shows the geographic impact of K Matoušovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Matoušovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Matoušovic more than expected).

Fields of papers citing papers by K Matoušovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Matoušovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Matoušovic. The network helps show where K Matoušovic may publish in the future.

Co-authorship network of co-authors of K Matoušovic

This figure shows the co-authorship network connecting the top 25 collaborators of K Matoušovic. A scholar is included among the top collaborators of K Matoušovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Matoušovic. K Matoušovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zachová, Kateřina, Petr Kosztyu, Josef Zadražil, et al.. (2020). Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy. Frontiers in Immunology. 11. 267–267. 19 indexed citations
2.
Kosztyu, Petr, Martin Hill, Leona Rašková Kafková, et al.. (2018). Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients. Kidney & Blood Pressure Research. 43(2). 350–359. 13 indexed citations
3.
Matoušovic, K, Jan Havlín, & O Schück. (2017). [Clinical evaluation of acid-base status: Henderson-Hasselbalch, or Stewart-Fencl approach?]. PubMed. 155(7). 365–369. 2 indexed citations
4.
Novák, Jan, Leona Rašková Kafková, Hitoshi Suzuki, et al.. (2011). IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells. Nephrology Dialysis Transplantation. 26(11). 3451–3457. 61 indexed citations
5.
Opatrná, Sylvie, et al.. (2009). Acid-Base Balance in Peritoneal Dialysis Patients: A Stewart-Fencl Analysis. Renal Failure. 31(8). 625–632. 2 indexed citations
6.
Feber, Janusz, J Spaténka, Tomáš Seeman, et al.. (2008). Urinary tract infections in pediatric renal transplant recipients – a two center risk factors study. Pediatric Transplantation. 13(7). 881–886. 14 indexed citations
7.
Městecký, Jiří, Milan Tomana, Zina Moldoveanu, et al.. (2008). Role of Aberrant Glycosylation of IgA1 Molecules in the Pathogenesis of IgA Nephropathy. Kidney & Blood Pressure Research. 31(1). 29–37. 67 indexed citations
8.
Julian, Bruce A., Robert Wyatt, K Matoušovic, et al.. (2007). IgA Nephropathy: A Clinical Overview. PubMed. 157. 19–26. 11 indexed citations
9.
Lischke, Robert, K Matoušovic, A Stolz, et al.. (2006). Initial Single-Center Experience With Sirolimus After Lung Transplantation. Transplantation Proceedings. 38(9). 3006–3011. 9 indexed citations
10.
Matoušovic, K, Jan Novák, Takeshi Yanagihara, et al.. (2006). IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrology Dialysis Transplantation. 21(9). 2478–2484. 52 indexed citations
11.
Tomana, Milan, Jan Novák, Bruce A. Julian, et al.. (1999). Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. Journal of Clinical Investigation. 104(1). 73–81. 384 indexed citations
12.
Matoušovic, K, Yasushi Tsuboi, Henry J. Walker, Joseph P. Grande, & Thomas P. Douša. (1997). Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. Journal of Laboratory and Clinical Medicine. 130(5). 487–495. 33 indexed citations
13.
Roßmann, P, et al.. (1997). Renal allograft biopsy: Image, interpretation, interventions. 3 indexed citations
14.
Matoušovic, K, Joseph P. Grande, Claudia C.S. Chini, Eduardo N. Chini, & Thomas P. Douša. (1995). Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.. Journal of Clinical Investigation. 96(1). 401–410. 64 indexed citations
15.
Chini, Claudia C.S., et al.. (1994). Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney International. 46(1). 28–36. 37 indexed citations
16.
Roßmann, P, et al.. (1993). Experimental adriamycin nephropathy. Fine structure, morphometry, glomerular polyanion, and cell membrane antigens. The Journal of Pathology. 169(1). 99–108. 9 indexed citations
17.
Roßmann, P, et al.. (1990). Experimental Ablation Nephropathy. Pathology - Research and Practice. 186(4). 491–506. 9 indexed citations
18.
Matoušovic, K, et al.. (1990). Pharmacokinetics of roxithromycin in kidney grafted patients under cyclosporin A or azathioprine immunosuppression and in healthy volunteers.. PubMed. 28(6). 262–7. 5 indexed citations
19.
Dobiášová, M, et al.. (1988). Effect of polyenoic phospholipid therapy on lecithin cholesterol acyltransferase activity in the human serum.. PubMed. 37(2). 165–72. 1 indexed citations
20.
Roßmann, P, et al.. (1982). Protamine-heparin aggregates. Virchows Archiv B Cell Pathology Including Molecular Pathology. 40(1). 81–98. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026